Vanguard Group’s PhenomeX Inc. Common Stock CELL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-3,519,033
| Closed | -$3.51M | – | 4589 |
|
|
2023
Q3 | $3.51M | Buy |
3,519,033
+39,449
| +1% | +$30.2K | ﹤0.01% | 3396 |
|
|
2023
Q2 | $1.7M | Sell |
3,479,584
-282,011
| -7% | -$231K | ﹤0.01% | 3719 |
|
|
2023
Q1 | $4.36M | Buy |
3,761,595
+553,052
| +17% | +$1.01M | ﹤0.01% | 3373 |
|
|
2022
Q4 | $8.6M | Buy |
3,208,543
+134,723
| +4% | +$355K | ﹤0.01% | 3022 |
|
|
2022
Q3 | $8.79M | Buy |
3,073,820
+650,538
| +27% | +$2.77M | ﹤0.01% | 3011 |
|
|
2022
Q2 | $12M | Sell |
2,423,282
-845,932
| -26% | -$4.43M | ﹤0.01% | 2891 |
|
|
2022
Q1 | $23.2M | Sell |
3,269,214
-1,166,204
| -26% | -$9.65M | ﹤0.01% | 2682 |
|
|
2021
Q4 | $80.6M | Buy |
4,435,418
+310,888
| +8% | +$6.71M | ﹤0.01% | 2095 |
|
|
2021
Q3 | $80.7M | Buy |
4,124,530
+461,448
| +13% | +$17.5M | ﹤0.01% | 2103 |
|
|
2021
Q2 | $164M | Buy |
3,663,082
+794,914
| +28% | +$36.8M | ﹤0.01% | 1742 |
|
|
2021
Q1 | $144M | Buy |
2,868,168
+1,862,170
| +185% | +$127M | ﹤0.01% | 1761 |
|
|
2020
Q4 | $89.9M | Buy |
1,005,998
+258,799
| +35% | +$21.8M | ﹤0.01% | 1880 |
|
|
2020
Q3 | $57.1M | Buy |
+747,199
| New | +$47.4M | ﹤0.01% | 1943 |
|
Vanguard Group's CELL Position: Q4 2023 in Review
Vanguard Group sold out of PhenomeX Inc. Common Stock (CELL) in Q4 2023, closing a stake of 3,519,033 shares — an estimated $3.51M sold.
Vanguard Group first reported a position in CELL in Q3 2020 and held it in 13 quarters. The position peaked at $164M in Q2 2021. 0 funds tracked by Wall St. Rank hold CELL as of Q4 2023.
- Vanguard Group reported no remaining PhenomeX Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
- Vanguard Group sold 3,519,033 PhenomeX Inc. Common Stock shares in Q4 2023, an estimated $3.51M.
- Vanguard Group first reported a position in PhenomeX Inc. Common Stock in Q3 2020 and held it in 13 quarters.
- Vanguard Group's PhenomeX Inc. Common Stock position peaked at $164M in Q2 2021.
- 0 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q4 2023.
Based on Vanguard Group's 13F filing for Q4 2023, filed 14 Feb 2024.